Jul 25, 2024, 21:47
New in Cardio-Oncology: VMAT shows no early cardiac function decline for left-sided breast cancer patients
Memorial Sloan Kettering Radiation Oncology shared on X:
“New in Cardio-Oncology breast cancer, Lior Braunstein:
VMAT for left-sided breast cancer RNI yielded no significant early decrement in echocardiographic parameters of cardiac function.
No patient exhibited significant LVEF changes or sustained decrements in strain.”
Source: Memorial Sloan Kettering Radiation Oncology/X
Authors: Anthony F. Yu, Charlie White, Zhigang Zhang, Jennifer E. Liu, Erin F Gillespie, Beryl McCormick, Atif J Khan, Richard M. Steingart, Simon N Powell, Oren Cahlon, Lior Z. Braunstein.
Anthony F. Yu
Atif J Khan
Beryl McCormick
Breast Cancer
breast cancer patients
cancer
cardiac function
Cardio-Oncology
Charlie White
Erin F Gillespie
Jennifer E. Liu
left-sided breast cancer
Lior Braunstein
Lior Z. Braunstein
LVEF changes
Memorial Sloan Kettering Radiation Oncology
OncoDaily
Oncology
Oren Cahlon
Richard M. Steingart
Simon N. Powell
VMAT
Zhigang Zhang